HURA
TuHURA BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HURA Profile
Tuhura Biosciences, Inc.
A biopharmaceutical company focused on the development and commercialization of new solid tumor cancer therapies
10500 University Center Dr., Suite 110, Tampa, FL 33612
--
TuHURA Biosciences, Inc., a Nevada corporation, was founded on June 24, 2009 as Berry Only, Inc. The company is a clinical-stage biopharmaceutical company. Kintara is committed to developing novel cancer therapies for patients with unmet medical needs. Kintara is developing two late-stage therapies to reduce risk and address clear unmet medical needs. The two programs are VAL-083 for glioblastoma (GBM) and REM-001 for cutaneous metastatic breast cancer (CMBC).
